Public law regulation of biomedical technologies: the Norwegian experience DOI

Georgy B. Romanovsky,

Ekaterina A. Romanovskaya,

Anastasia I. Dasaeva

et al.

Current Issues of the State and Law, Journal Year: 2024, Volume and Issue: 4(4), P. 530 - 537

Published: Jan. 1, 2024

A comparative study of the legal regulation biomedical technologies is conducted. The purpose to conduct a examination Norwegian experience, which an example conservative ap-proach based on most careful permission for innovation in such sensitive area. main provisions Law December 5, 2003, No. 100 “On Medical Use Biotechnology, etc. (Biotechnology Law)” are ana-lyzed detail. This law observance universal principles biomedicine – respect human dignity, rights and personal inviolability, non-discrimination basis heredity, pro-motion bioethics. restrictions imposed medical workers when implementing as-sisted reproductive shown. For example, Norway country where surrogacy prohibited, birth children using assisted reproduction possible only after thorough couple possibility raising child appropriate conditions. Special requirements presented obtaining consent use various biological objects (tissues, cells, aborted material) research purposes. It highlighted that special legislation force determines regime biobanks. concluded presence strict rules correlates with level high trust public health system.

Language: Английский

Embryonic BPF exposure induces neurodevelopmental and neurobehavioral toxicity by affecting neural stem cell proliferation in Drosophila DOI

Binquan Wang,

Ziyi Yang, Ke Zhang

et al.

Environmental Pollution, Journal Year: 2025, Volume and Issue: unknown, P. 125844 - 125844

Published: Feb. 1, 2025

Language: Английский

Citations

0
Public law regulation of biomedical technologies: the Norwegian experience DOI

Georgy B. Romanovsky,

Ekaterina A. Romanovskaya,

Anastasia I. Dasaeva

et al.

Current Issues of the State and Law, Journal Year: 2024, Volume and Issue: 4(4), P. 530 - 537

Published: Jan. 1, 2024

A comparative study of the legal regulation biomedical technologies is conducted. The purpose to conduct a examination Norwegian experience, which an example conservative ap-proach based on most careful permission for innovation in such sensitive area. main provisions Law December 5, 2003, No. 100 “On Medical Use Biotechnology, etc. (Biotechnology Law)” are ana-lyzed detail. This law observance universal principles biomedicine – respect human dignity, rights and personal inviolability, non-discrimination basis heredity, pro-motion bioethics. restrictions imposed medical workers when implementing as-sisted reproductive shown. For example, Norway country where surrogacy prohibited, birth children using assisted reproduction possible only after thorough couple possibility raising child appropriate conditions. Special requirements presented obtaining consent use various biological objects (tissues, cells, aborted material) research purposes. It highlighted that special legislation force determines regime biobanks. concluded presence strict rules correlates with level high trust public health system.

Language: Английский

Citations

0